Heart study tests safer blood thinner for High-Risk patients
NCT ID NCT07383155
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two blood thinners, bivalirudin and heparin, used during a heart procedure called PCI in people with acute coronary syndrome who are at high risk of bleeding. About 5,270 participants will be randomly assigned to receive one of the two drugs. The goal is to see which one better prevents serious heart problems and major bleeding within 30 days.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE CORONARY SYNDROMES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can immune cells predict how well the heart heals after an attack?
- Drinking water may shield kidneys during emergency heart procedures
- Can a tailored Blood-Thinner combo prevent second heart attacks without causing bleeding?
- Can a personalized exercise plan boost heart rehab for seniors?
- When is the best time to fix other blocked arteries after a heart attack?
- Can a cholesterol-lowering combo also shrink fatty liver in diabetic heart patients?